GDERF
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes ACTINICA, Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Sool… Read more
Market Cap & Net Worth: GDERF (GDERF)
GDERF (OTCGREY:GDERF) has a market capitalization of $25.38 Billion ($25.38 Billion) as of March 18, 2026. Listed on the OTCGREY stock exchange, this USA-based company holds position #1206 globally and #927 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying GDERF's stock price $108.10 by its total outstanding shares 234823853 (234.82 Million).
GDERF Market Cap History: 2024 to 2025
GDERF's market capitalization history from 2024 to 2025. Data shows growth from $22.78 Billion to $25.38 Billion (0.00% CAGR).
GDERF Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how GDERF's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
5.13x
GDERF's market cap is 5.13 times its annual revenue
1.02x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
98.61x
GDERF's market cap is 98.61 times its annual earnings
10.35x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $22.78 Billion | $4.44 Billion | $231.00 Million | 5.13x | 98.61x |
Competitor Companies of GDERF by Market Capitalization
Companies near GDERF in the global market cap rankings as of March 18, 2026.
Key companies related to GDERF by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- United Therapeutics Corporation (NASDAQ:UTHR): Ranked #917 globally with a market cap of $21.42 Billion USD.
- Sandoz Group AG (OTCQX:SDZXF): Ranked #1127 globally with a market cap of $17.13 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #917 | United Therapeutics Corporation | NASDAQ:UTHR | $21.42 Billion | $540.02 |
| #1127 | Sandoz Group AG | OTCQX:SDZXF | $17.13 Billion | $41.36 |
GDERF Historical Marketcap From 2024 to 2025
Between 2024 and today, GDERF's market cap moved from $22.78 Billion to $ 25.38 Billion, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $25.38 Billion | +11.44% |
| 2024 | $22.78 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of GDERF was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $25.38 Billion USD |
| MoneyControl | $25.38 Billion USD |
| MarketWatch | $25.38 Billion USD |
| marketcap.company | $25.38 Billion USD |
| Reuters | $25.38 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.